Low-level laser therapy can reduce lipopolysaccharide-induced contractile force dysfunction and TNF-α levels in rat diaphragm muscle

Lasers in Medical Science

Volumn 21, Issue 4, 2006, Pages 238-244

  Aimbire, F ^a   Lopes Martins, R A B ^b   Castro Faria Neto, H C ^c   Albertini, R ^a   Chavantes, M C ^b   Pacheco, M T T ^a   Leonardo, P S L M ^b   Iversen, V V ^d   Bjordal, J M ^d,e  

^a INSTITUTO DE PESQUISA E DESENVOLVIMENTO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSITY OF BERGEN   (Norway)

^e BERGEN UNIVERSITY COLLEGE   (Norway)

Author keywords

Chlorpromazine (CPZ); Chronic inflammation disease; Diode Ga AsI Al laser; Electrical muscle stimulation

Indexed keywords

ALUMINUM; CHLORPROMAZINE; GALLIUM; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAPHRAGM MUSCLE; DIODE LASER; INHIBITION KINETICS; LOW LEVEL LASER THERAPY; MUSCLE CONTRACTION; MUSCLE EXCITATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY FUNCTION;

ANIMALS; CHLORPROMAZINE; DIAPHRAGM; LASER THERAPY, LOW-LEVEL; LIPOPOLYSACCHARIDES; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESPIRATORY INSUFFICIENCY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845313936     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10103-006-0405-y     Document Type: Article

References (67)

1. Fahal IH, Bell GM, Bone JM, Edwards RH (1997) Physiological abnormalities of skeletal muscle in dialysis patients. Nephrol Dial Transplant 12:119-127
2. American Thoracic Society and European Respiratory Society (1999) Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:S1-S40 (Suppl)
3. Claesson BE, Svensson NG, Gotthardsson L, Garden B (1992) A food borne outbreak of group A streptococcal disease at a birthday party. Scan J Infect Dis 24:577-586
4. Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, Coats AJ (1997) Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 30:1758-1764
5. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen W, Shou Z, Liu P (1999) Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 99:1492-1498
6. Wilcox P, Osborne S, Bressler B (1992) Monocyte inflammatory mediators impair in vitro hamster diaphragm contractility. Am Rev Respir Dis 146:462-466
7. Di Francia M, Barbier D, Mege JL, Orehek J (1994) Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150:1453-1455
8. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe heart failure. N Engl J Med 223:236-241
9. Spooner CE, Markowitz NP, Saravolatz LD (1992) The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 62:S11-S17
10. Dorge SE, Roux-Lombard P, Dayer JM, Koch KM, Frei U, Lonnemann G (1994) Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation 58:1000-1008
11. Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J, Poole-Wilson PA, Coats AJ, Anker SD (1998) Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 32:393-397
12. St. Pierre BA, Kasper CE, Lindsey AM (1992) Fatigue mechanisms in patients with cancer: effects of tumor necrosis factor and exercise on skeletal muscle. Oncol Nurs Forum 19:419-425
13. Roubenoff R (1995) Tumor necrosis factor and AIDS. Am J Clin Nutr 61:161-162
14. Nakashima J, Tachibana M, Ueno M, Baba S, Tazaki H (1995) Tumor necrosis factor and coagulopathy in patient with prostate cancer. Cancer Res 55:4881-4885
15. Vreugdenhil G, Lowenberg B, VanEijk HG, Swaak JG (1992) Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Investig 22:488-493
16. Wilcox PG, Wakai Y, Walley KR, Cooper DJ, Road J (1994) Tumor necrosis alpha decreases in vivo diaphragm contractility in dogs. Am J Respir Crit Care Med 150:1368-1373
17. Li X, Moody MR, Engel D, Walker S, Clubb FJ, Sivasubramanian N, Mann dL, Reid MB (2000) Cardiacspecific overexpression of TNF-α causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102:1690-1696
18. Alloatti G, Penna C, Mariano F, Camussi G (2000) Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-α. Am J Physiol Regul Integr Comp Physiol 279:R2156-R2163
19. Tavares de Lima W, Steil AA, Russo M, Starobinas N, Teixeira CFP, Jancar S (1998) Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury. Eur J Pharmacol 358:69-75
20. Jansen M, Hendriks T, Knapen M, van Kempen L, van der Meer J, Goris R (1998) Chlorpromazine down-regulates tumor necrosis factor and attenuates experimental multiple organ dysfunction syndrome in mice. Crit Care Med 26(7):1244-1250
21. Gadina M, Bertini M, Mengozzi M, Zandalasini M, Mantovani A, Ghezzi P (1991) Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxin shock. J Exp Med 173:1305-1310
22. Bertini R, Mengozzi M, Bianchi M (1991) Chlorpromazine protection against interleukin-1 and tumor necrosis factor-mediated activities in vivo. Int J Immunopharmacol 13:1085-1090
23. Pilkington CA, Wedderburn IR (2005) Pediatric idiopathic inflammatory disease: recognition and management. Drugs 65(10):1355-1365
24. Brosseau L, Wells G, Marchand S, Gaboury I, Stokes B, Morin M, Casimiro L, Yonge K, Tugwell P (2005) Randomized controlled trial on low level laser therapy (LLLT) in the treatment of osteoarthritis (OA) of the hand. Lasers Surg Med 36(3):210-219
25. Gur A, Cosut A, Sarac AJ (2003) Efficacy of different therapy regimes of low-power laser in painful osteoarthritis of the knee: a double-blind and randomized-controlled trial. Lasers Surg Med 33:330-338
26. Bjordal JM, Johnson MI, Iversen VV, Aimbire F, Lopes-Martins RAB (2005) Low Level Laser Therapy (LLLT) in acute pain. A systematic review of possible mechanisms of low-level laser therapy action and clinical effects in randomized placebo-controlled trials. Photomed Laser Surg 24(1):160-170
27. Brosseau L, Welch V, Wells G, deBie R, Gam A, Harman K (2005) Low level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 4. DOI 10.1002/14651858.CD002049
28. Bouma MG, Buurman WA, van den Wildenberg FA (1996) Low energy laser irradiation fails to modulate the inflammatory function of human monocytes and endothelial cells. Lasers Med Surg 19:207-215
29. 2 and interleukin-1β production by low power laser irradiation in stretched human periodontal ligament cells. J Dent Res 74:1382-1388
30. 2 and cyclooxygenase-2 in human gingival fibroblast. Eur J Oral Sci 108(1):29-34
31. Campana V, Moya M, Gavotto A, Soriano F, Juri H, Spitale L (1999) The relative effects of HeNe laser and meloxicam on experimentally induced inflammation. Laser Ther 11(1):36-41
32. Albertini R, Aimbire FS, Correa FI, Ribeiro W, Cogo JC, Antunes E, Teixeira SA, De Nucci G, Castro-Faria-Neto HC, Zângaro RA, Lopes-Martins RAB (2004) Effects of different protocols doses of low power laser gallium-aluminum-arsenate (Ga-Al-As) laser radiation (650 nm) on carrageenan induced paw oedema. J Photochem Photobiol B 72(2-3): 101-107
33. Aimbire F, Albertini R, Leonardo PSLM, Castro Faria Neto HC, Iversen VV, Lopes-Martins RAB, Bjordal JM (2006) Low level laser therapy induces dose-dependent reduction of TNFα-levels in acute inflammation. Photomed Laser Surg 24:33-37
34. Nicolau RA, Martinez MS, Rigau J, Tomàs J (2002) Neurotransmitter release changes induced by low power 830 nm diode laser irradiation on the neuromuscular junctions of the mouse. Lasers Surg Med 35:236-241
35. Hussain SN (1998) Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 179:125-134
36. Braith RW, Limacher MC, Legget SH, Pollock ML (1993) Skeletal muscle strength in heart transplant recipients. J Heart Lung Transplant 12:1018-1023
37. Simon AM, Zittoun R (1999) Fatigue in cancer patients. Curr Opin Oncol 11:244-249
38. Cianfrocca M, Von Roenn JH (1997) Wasting and cachexia in patients with HIV. Aids Patient Care STDS 11:259-267
39. Fujimura N, Sumita S, Aimono M, Masuda Y, Shichinohe Y, Narimatsu E, Namiky A (2000) Effect of free radical scavengers on diaphragmatic contractility in septic peritonitis. Am J Respir Crit Care Med 162:2159-2165
40. Taille C, Foresti R, Lanone S, Zedda C, Greeen C, Aubier M, Motterlini R, Boczkowski J (2001) Protective role of heme oxygenases against endotoxin-induced diaphragmatic dysfunction in rats. Am J Respir Crit Care Med 163:753-761
41. Comtois AS, Barriero E, Huang PL, Marette A, Perrault M, Hussain SNA (2001) Lipopolysaccharide-induced diaphragmatic contractile dysfunction and sarcolemmal injury in mice lacking the neuronal nitric oxide synthase. Am J Respir Crit Care Med 163:977-982
42. Kotler DP (2000) Cachexia. Ann Intern Med 133:622-634
43. Reid MB, Lännergren J, Westerblad H (2002) Respiratory and limb muscle weakness induced by tumor necrosis factor-α. Am J Respir Crit Care Med 166:479-484
44. Hopkins PM (1996) Human recombinant TNF-alpha affects rat diaphragm muscle in vitro. Intensive Care Med 153:1611-1615
45. Wilcox P, Milliken C, Bressler B (1996) High-dose tumor necrosis factor alpha produces an impairment of hamster diaphragm contractility. Attenuation with a prostaglandin inhibitor. Am J Respir Crit Care Med 153:1611-1615
46. Diaz PT, Julian MW, Wewers MD, Clanton TL (1993) Tumor necrosis factor and endotoxin do not directly affect in vitro diaphragm function. Am Rev Respir Dis 148:281-287
47. Yokohama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92:2302-2312
48. Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT (1986) Cachexia/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. J Exp Med 164:1368-1373
49. Kandolf-Sekulovic L, Kataranovski M, Pavlovic MD (2003) Immunomodulatory effects of low-intensity near-infrared laser irradiation on contact hypersensitivity reaction. Photodermaltol Photoimmunol Photomed 19(4):202-212
50. Shefer G, Oron U, Irintchev A, Werning A, Halevy O (2001) Skeletal muscle cell activation by low-energy laser irradiation: a role for the MAPK/ERK pathway. J Cell Physiol 187(1): 73-80
51. Campana V, Moya M, Gavotto A, Simes JC, Spitale L, Soriano F (2003) He-Ne laser on microcrystalline arthropathies. J Clin Laser Med Surg 21(2):99-103
52. Bjordal J, Couppé C, Ljunggreen A (2001) A literature review of possible effective intervals of red and infrared irradiation for enhanced tissue repair in the locomotor system. In: "Abstract Book, 9th Congress of European Society for Photobiology", p 190
53. Giuliani A, Fernandez M, Farinelli M, Baratto L, Capra R, Rovetta G (2004) Very low level laser therapy attenuates edema and pain in experimental models. Int J Tissue React 26(1-2):29-37
54. Karu T, Pyatribat LV, Ryabykh T (1997) Nonmonotonic behaviour of the dose dependence of the radiation effect on cells in vitro exposed to pulsed laser radiation at 820 nm wavelength. Lasers Surg Med 21:485-492
55. Halse R, Pearson SL, McCormack J, Yeaman SJ, Taylor R (2001) Effects of tumor necrosis factor-α on insulin action in cultured human muscle cells. Diabetes 50:1102-1109
56. Krause KM, Moody MR, Andrade FH, Taylor AA, Miller CC, Lester K, Reid MB (1998) Peritonitis cause diaphragm weakness in rats. Am J Respir Crit Care Med 157:1277-1282
57. Goubel F, Pigot A, Allaf O, Verleye M, Gillardin JM (1995) Endotoxins modify muscle fatigue characteristics. Fundam Clin Pharmacol 9(2):202-204
58. Anderson JL, Williams G, Head SI (2001) The role of nitric oxide in diaphragmatic dysfunction in endotoxemic rats. Muscle Nerve 24(1):30-36
59. Goldman JA (1981) Investigative studies of laser technology in rheumatology and immunology. Biomedical laser technology clinical applications. Springer, Berlin Heidelberg New York
60. Basford JR (1995) Low intensity laser therapy: still not an established clinical tool. Lasers Surg Med 16(4):331-342
61. Beckerman H, de Bie RA, Bouter LM, de Cuyper HJ, Oostendorp RA (1992) The efficacy of laser therapy for musculoskeletal and skin disorders: a criteria-based metaanalysis of randomized clinical trials. Phys Ther 72(7):483-491
62. Bibikova A, Oron U (1993) Promotion of muscle regeneration in the toad (Bufo viridis) gastrocnemius muscle by low-energy laser irradiation. Anat Rec 235(3):374-380
63. Amaral AC, Parizotto NA, Salvini TF (2001) Dose-dependency of low-energy HeNe laser effect in regeneration of skeletal muscle in mice. Lasers Med Sci 16(1):44-51
64. Goluszko E, Deng C, Poussin A, Christadoss P (2002) Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis. J Neuroimmunol 122:85-93
65. Zhang GX, Navikas V, Link H (1997) Cytokines and the pathogenesis of myasthenia gravis. Muscle Nerve 20:543-552
66. Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE (2005) The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum 34(6):819-836
67. Brosseau L, Robinson V, Wells G, Debie R, Gam A, Harman K et al (2005) Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev 4:CD002049